53 studies found for:    Open Studies | "Vitamin K"
Show Display Options
Rank Status Study
1 Recruiting Vitamin K and Glucose Metabolism in Children at Risk for Diabetes (Vita-K 'n' Kids Study)
Conditions: Obesity;   Insulin Resistance;   Insulin Sensitivity;   Beta-Cell Dysfunction;   Prediabetes
Interventions: Dietary Supplement: Placebo-Control;   Dietary Supplement: Low-Dose Vitamin K2 (menaquinone-7; 45 mcg/d);   Dietary Supplement: High-Dose Vitamin K2 (menaquinone-7; 90 mcg/d)
2 Unknown  Vitamin K as Additive Treatment in Osteoporosis
Condition: Post-Menopausal Osteoporosis
Interventions: Drug: Phylloquinone;   Drug: Menaquinone (MK4);   Drug: placebo
3 Recruiting Vitamin K and Glucose Metabolism in Adults at Risk for Diabetes (Vita-K 'n' Adults Study)
Conditions: Obesity;   Insulin Resistance;   Insulin Sensitivity;   Beta-Cell Dysfunction;   Prediabetes
Interventions: Dietary Supplement: Placebo;   Dietary Supplement: Low-Dose Vitamin K2 Supplement (menaquinone-7; 90-mcg/d);   Dietary Supplement: High-Dose Vitamin K2 Supplement (menaquinone-7; 180-mcg/d)
4 Recruiting Vitamin K1 to Slow Progression of Vascular Calcification in HD Patients
Condition: Cardiovascular Diseases
Intervention: Drug: Vitamin K1
5 Recruiting Evaluation of Vitamin K Supplementation for Calcific Uremic Arteriolopathy
Conditions: Calciphylaxis;   Calcific Uremic Arteriolopathy
Interventions: Dietary Supplement: Vitamin K;   Other: Placebo
6 Unknown  Vitamin K2 and Vessel Calcification in Chronic Kidney Disease Patients
Conditions: Kidney Diseases;   Coronary Artery Calcification
Interventions: Drug: Vitamin K2+10μg cholecalciferol;   Drug: Vitamin D
7 Recruiting Vitamin K Supplementation in Patients on Hemodialysis
Conditions: End Stage Renal Failure on Dialysis;   Atrial Fibrillation
Intervention: Drug: vitamin K1
8 Recruiting Vitamin K to Attenuate Coronary Artery Calcification in Hemodialysis Patients
Condition: Endstage Kidney Disease
Interventions: Drug: Vitamin K1;   Drug: Chrystalline Lactose
9 Recruiting The Effects of Vitamin K2 Supplementation on the Progression of Coronary Artery Calcification
Condition: Coronary Artery Disease
Interventions: Dietary Supplement: Menaquinone-7 (Vitamin K2);   Other: Placebo capsules
10 Recruiting A Study Exploring Two Strategies of Rivaroxaban (JNJ39039039; BAY-59-7939) and One of Oral Vitamin K Antagonist in Patients With Atrial Fibrillation Who Undergo Percutaneous Coronary Intervention
Conditions: Atrial Fibrillation;   Percutaneous Coronary Intervention
Interventions: Drug: rivaroxaban 2.5 mg;   Drug: rivaroxaban 15 mg;   Drug: rivaroxaban 10 mg;   Drug: aspirin (ASA);   Drug: vitamin K antagonist (VKA);   Drug: clopidogrel;   Drug: prasugrel;   Drug: ticagrelor
11 Not yet recruiting Vitamin K2 Effect on Vascular Stiffening in Subjects With a Poor Vitamin K-status
Condition: Vascular Stiffness
Interventions: Dietary Supplement: Menaquinone-7;   Dietary Supplement: Placebo
12 Not yet recruiting Benefit/Risk in Real Life of New Oral Anticoagulants and Vitamin K Antagonists in Patients Aged 80 Years and Over
Condition: Atrial Fibrillation
Interventions: Drug: Direct oral antocoagulant: dabigatran, rivaroxaban, apixaban;   Drug: Vitamin K antagonist: warfarin, fluindione, acenocoumarol
13 Not yet recruiting Phase II Randomized Placebo-controlled Study With Vitamin K2 in Asymptomatic Calcified Carotid Stenosis
Conditions: Carotid Disease;   Atherosclerosis
Intervention: Drug: Vitamin K2 (Menaquinone)
14 Not yet recruiting Study Apixaban to Vitamin K Antagonist for the Prevention of Stroke or Systemic Embolism and Bleeding in Patients With Non-valvular Atrial Fibrillation and Acute Coronary Syndrome/Percutaneous Coronary Intervention
Condition: Acute Coronary Syndromes
Interventions: Drug: Apixaban;   Drug: vitamin K antagonist;   Drug: Acetylsalicylic acid;   Other: Acetylsalicylic acid placebo
15 Recruiting Apixaban During Atrial Fibrillation Catheter Ablation: Comparison to Vitamin K Antagonist Therapy
Condition: Atrial Fibrillation
Interventions: Drug: Vitamin K antagonist;   Drug: Apixaban
16 Recruiting Study Of The Blood Thinner, Apixaban, For Patients Who Have An Abnormal Heart Rhythm (Atrial Fibrillation) And Expected To Have Treatment To Put Them Back Into A Normal Heart Rhythm (Cardioversion)
Condition: Atrial Fibrillation
Interventions: Drug: Apixaban;   Drug: Parenteral heparin and/or oral Vitamin K antagonist
17 Recruiting Sorafenib Plus Vitamin K1 Versus Sorafenib in Advanced Hepatocellular Carcinoma
Condition: Hepatocellular Carcinoma
Interventions: Drug: Sorafenib 400mg twice daily + intravenous infusion ofVit K1;   Drug: Sorafenib 400 mg twice daily + Intravenousinfusion of placebo
18 Recruiting Biomarkers and Antithrombotic Treatment in Cervical Artery Dissection - TREAT-CAD
Condition: Cervical Artery Dissection
Interventions: Drug: Acetylsalicylic acid;   Drug: vitamin K-antagonist
19 Not yet recruiting Real-Life Evidence on Stroke Prevention in SPAF
Condition: Atrial Fibrillation (Prevention of Stroke)
Interventions: Drug: Rivaroxaban (Xarelto, BAY59-7939);   Drug: Vitamin K antagonists
20 Unknown  Efficacy and Safety of the Prophylactic Use of Doxycycline +/- Vitamin K Cream
Condition: Metastatic Colorectal Cancer
Interventions: Device: Reconval K1 Cream;   Device: Reconval Cream

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years